Scarica l'app Stockscreener
85.90
0.48%
0.41
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$85.49
Aprire:
$86.36
Volume 24 ore:
153.32K
Relative Volume:
0.69
Capitalizzazione di mercato:
$1.44B
Reddito:
$5.82B
Utile/perdita netta:
$-373.54M
Rapporto P/E:
-3.81
EPS:
-22.546
Flusso di cassa netto:
$-87.01M
1 W Prestazione:
+3.00%
1M Prestazione:
-4.31%
6M Prestazione:
+297.13%
1 anno Prestazione:
+285.59%
Intervallo 1D:
$83.42
$87.09
Intervallo di 1 settimana:
$81.16
$88.12
Portata 52W:
$7.48
$133.04
Agilon Health Inc Stock (AGL) Company Profile
Nome
Agilon Health Inc
Settore
Industria
Telefono
562-256-3800
Indirizzo
440 POLARIS PARKWAY, WESTERVILLE
Compare AGL vs HCA, THC, EHC, DVA, FMS
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AGL
Agilon Health Inc
|
85.90 | 1.44B | 5.82B | -373.54M | -87.01M | -22.55 |
HCA
Hca Healthcare Inc
|
460.75 | 99.75B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
266.91 | 21.49B | 21.46B | 2.65B | 3.35B | 19.23 |
EHC
Encompass Health Corp
|
124.33 | 12.27B | 6.07B | 793.80M | 464.40M | 5.9914 |
DVA
Davita Inc
|
182.08 | 11.62B | 13.84B | 1.10B | 1.49B | 10.42 |
FMS
Fresenius Medical Care Ag Adr
|
21.08 | 11.22B | 22.44B | 1.35B | 2.03B | 1.9002 |
Agilon Health Inc Stock (AGL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-09-15 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2026-08-11 | Aggiornamento | Citigroup | Sell → Neutral |
| 2026-07-23 | Downgrade | Citigroup | Neutral → Sell |
| 2026-05-26 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2026-05-07 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2026-05-07 | Aggiornamento | Jefferies | Hold → Buy |
| 2026-05-04 | Downgrade | JP Morgan | Neutral → Underweight |
| 2025-08-20 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2025-08-06 | Downgrade | Citigroup | Buy → Neutral |
| 2025-04-25 | Aggiornamento | Citigroup | Neutral → Buy |
| 2025-04-08 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2025-01-10 | Aggiornamento | Citigroup | Sell → Neutral |
| 2025-01-10 | Iniziato | Needham | Hold |
| 2024-12-16 | Iniziato | Macquarie | Neutral |
| 2024-12-11 | Iniziato | Bernstein | Mkt Perform |
| 2024-11-11 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| 2024-11-08 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2024-10-30 | Downgrade | Citigroup | Neutral → Sell |
| 2024-10-02 | Downgrade | BofA Securities | Buy → Underperform |
| 2024-05-30 | Iniziato | Robert W. Baird | Neutral |
| 2024-04-22 | Iniziato | Citigroup | Neutral |
| 2024-03-06 | Iniziato | Barclays | Underweight |
| 2024-02-26 | Downgrade | Jefferies | Buy → Hold |
| 2024-02-26 | Downgrade | TD Cowen | Outperform → Market Perform |
| 2024-01-08 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2024-01-08 | Downgrade | Stifel | Buy → Hold |
| 2024-01-08 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2024-01-05 | Downgrade | JP Morgan | Overweight → Neutral |
| 2024-01-05 | Downgrade | Truist | Buy → Hold |
| 2023-12-11 | Downgrade | Goldman | Buy → Neutral |
| 2023-12-06 | Iniziato | JMP Securities | Mkt Outperform |
| 2023-11-21 | Downgrade | Deutsche Bank | Buy → Hold |
| 2023-10-20 | Iniziato | The Benchmark Company | Buy |
| 2023-06-13 | Iniziato | Evercore ISI | In-line |
| 2022-12-09 | Iniziato | Stifel | Buy |
| 2022-09-14 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-09-12 | Iniziato | Goldman | Buy |
| 2022-09-07 | Ripresa | Truist | Buy |
| 2022-06-24 | Iniziato | BTIG Research | Neutral |
| 2022-03-30 | Iniziato | Guggenheim | Buy |
| 2021-10-20 | Iniziato | Jefferies | Buy |
| 2021-09-27 | Iniziato | SVB Leerink | Outperform |
| 2021-09-10 | Iniziato | Cowen | Outperform |
| 2021-05-11 | Iniziato | William Blair | Outperform |
| 2021-05-10 | Iniziato | BofA Securities | Buy |
| 2021-05-10 | Iniziato | Deutsche Bank | Buy |
| 2021-05-10 | Iniziato | Goldman | Buy |
| 2021-05-10 | Iniziato | JP Morgan | Overweight |
| 2021-05-10 | Iniziato | Truist | Buy |
| 2021-05-10 | Iniziato | Wells Fargo | Overweight |
| 2021-05-10 | Iniziato | Wolfe Research | Outperform |
Mostra tutto
Agilon Health Inc Borsa (AGL) Ultime notizie
A 4:30 p.m. call will cover agilon health's third-quarter results on Nov. 4. - Stock Titan
Agilon Health Adds Jackson Clinic to Senior Health Connect ACO - Yahoo Finance
agilon health and The Jackson Clinic Advance Their Partnership Through Senior Health Connect ACO - Business Wire
agilon health, inc. (AGL) options chain - Yahoo Finance Australia
agilon health, inc. (AGL) options chain - Yahoo Finance Australia
An Illinois clinic joins a care program expected to help reach about 21,000 more people on Medicare - Stock Titan
agilon health and Springfield Clinic Broaden Partnership Through Senior Health Connect ACO - Business Wire
agilon health and Springfield Clinic Broaden Partnership Through Senior Health Connect ACO - Yahoo Finance
How Investors Are Reacting To agilon health (AGL) Expanding Full-Risk Medicare Partnership With Family Practice Center - Yahoo Finance
agilon health (AGL) On Bernstein Upgrade And A Turnaround Story That Still Looks Undervalued - Yahoo Finance
Stocks making big moves yesterday: Dave & Buster's, Vishay Intertechnology, DocuSign, SentinelOne, and agilon health - Yahoo Finance
agilon health (AGL) Stock Trades Up, Here Is Why - Yahoo Finance
Is Agilon Health Inc (AGL) a Bargain After 3.1% Drop? GF Value Says Undervalued - GuruFocus
A Pennsylvania doctor group serving more than 200,000 patients will join agilon’s Medicare care program. - Stock Titan
agilon health and Family Practice Center Expand Relationship Through Senior Health Connect ACO - Business Wire
agilon health and Family Practice Center Expand Relationship Through Senior Health Connect ACO - Yahoo Finance
agilon health Inc (AGL) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
A Look at Agilon Health Inc (AGL) After 5.0% Decline -- GF Value $91.63 vs Price $87.89 - GuruFocus
agilon health Inc (AGL) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Is Agilon Health (AGL) Outperforming Other Medical Stocks This Year? - Yahoo Finance
agilon health Announces Revised Presentation Time at the 2026 Jefferies Healthcare Services and Technology Conference - Business Wire
Analysts Offer Insights on Healthcare Companies: Eloxx Pharmaceuticals (ELOX), Cingulate Inc (CING) and Agilon Health (AGL) - theglobeandmail.com
J.P. Morgan Maintains Agilon Health(AGL.US) With Sell Rating, Raises Target Price to $85 - Moomoo
Truist reiterates Hold on agilon health stock, $112 target By Investing.com - Investing.com Nigeria
Truist reiterates Hold on agilon health stock, $112 target By Investing.com - Investing.com Canada
Truist reiterates Hold on agilon health stock, $112 target By Investing.com - Investing.com UK
Why Fast-paced Mover Agilon (AGL) Is a Great Choice for Value Investors - Eastern Progress
Is Agilon Health Inc (AGL) Overvalued After 4.2% Rally? GF Value - GuruFocus
agilon health to Participate in Upcoming Conferences - Yahoo Finance
Agilon Health (NYSE:AGL) Trading Up 5.4%Here's Why - MarketBeat
agilon health is set for three September health conference events - Stock Titan
Q2 Earnings Highlights: agilon health (NYSE:AGL) Vs The Rest Of The Outpatient & Specialty Care Stocks - Yahoo Finance
AQR Capital Management Trims Agilon Health (AGL) Stake Amid Stoc - GuruFocus
agilon health (AGL) insider’s 17-share move is just tax withholding - Stock Titan
Q2 Earnings Highlights: agilon health (NYSE:AGL) Vs The Rest Of The Outpatient & Specialty Care Stocks - Barchart.com
Q2 Earnings Highlights: agilon health (NYSE:AGL) Vs The Rest Of The Outpatient & Specialty Care Stocks - The Globe and Mail
Agilon Health, Inc. (NYSE:AGL) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat
Bernstein Reaffirms Their Hold Rating on Agilon Health (AGL) - The Globe and Mail
Agilon Health Inc (AGL) Stock Up 9.0% but GF Value Says Overvalued -- GF Score: 71/100 - GuruFocus
Agilon Health (NYSE:AGL) Trading 8.5% HigherHere's What Happened - MarketBeat
Should agilon health’s (AGL) Profit Rebound and Higher Guidance Prompt a Fresh Look From Investors? - simplywall.st
Should agilon health’s (AGL) Profit Rebound and Higher Guidance Prompt a Fresh Look From Investors? - simplywall.st
AGL|agilon health inc|Price:92.730|Chg%:-0.910 - TradingKey
Should agilon health’s (AGL) Profit Rebound and Higher Guidance Prompt a Fresh Look From Investors? - webull.com
5 Insightful Analyst Questions From agilon health’s Q2 Earnings Call - Yahoo Finance
Agilon Health (NYSE:AGL) Valuation Debate Grows After Guidance - Kalkine Media
Agilon Health (AGL) Q2 2026 Earnings Call Transcript - AOL.com
Agilon Health (AGL) Q2 2026 Earnings Call Transcript - The Globe and Mail
Has Agilon Health (AGL) Outpaced Other Medical Stocks This Year? - Yahoo Finance
AQR Capital discloses 4.15% agilon health (AGL) stake in Schedule 13G/A - Stock Titan
Agilon Health Inc Azioni (AGL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Agilon Health Inc Azioni (AGL) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Wulf John William | Director |
Nov 12 '25 |
Buy |
0.63 |
81,000 |
50,941 |
365,857 |
1.26%
0.91%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):